Receives Development Milestone Payment of CTX-177 (ONO-7018), a MALT1 Inhibitor, According to License Agreement with Ono Pharmaceutical
  • Feb 16, 2023
サブ-ナビゲーション
  • Company
  • Science/Pipleline
  • 現在位置:News
  • Investor Relations
  • Career
  • Contact
  • Privacy Policy
  • Term of use
  • Sitemap

Receives Development Milestone Payment of CTX-177 (ONO-7018), a MALT1 Inhibitor, According to License Agreement with Ono Pharmaceutical

  • Feb 16, 2023

VIEW ALL

ページの先頭へ
ページの先頭へ
  • footer-content
  • menu
  • gnavi-box